Goldman Sachs Downgrades InterMune To Neutral

Analysts at Goldman Sachs downgraded InterMune

from Buy to Neutral. InterMune shares have surged 268.44% over the past 52 weeks, while the S&P 500 index has gained 17.18% in the same period. InterMune's shares dropped 2.51% to $50.75 in pre-market trading.